Klarna Is Selling Less Volume on Purpose
The GMV slowdown is deliberate. Investors pricing it as demand are wrong.
2026
MRNA Doubled on Data Nobody Has Seen Yet
Here is the uncomfortable fact at the center of one of biotech’s wildest two-day swings: nobody has seen the data….
Two Miners to Own. One to Avoid.
Agnico Eagle and Kinross just posted record cash flow. Newmont is shrinking while costs rise.
Four Memory Stocks at the Center of AI’s Biggest Bottleneck
HBM is sold out. DRAM is tightening. These four companies are not equally priced for what comes next.
The $514B Backlog vs. 3.6B Daily Users
Alphabet and Meta are both spending the most capital in their histories on AI. The asset that determines the winner is different for each.
Five Dividend Fortresses for an Uncertain Market
The macro backdrop right now is genuinely uncomfortable. The threat of recession has hung over the market for much of…
Rambus Just Got Cheaper. The Market Is Reading the Wrong Number.
A 20% post-earnings drop on record revenue is not a verdict on the business. It is a timing misread on the most important memory IP ramp of 2027.
WMT Reports Thursday. The Margin Gap Matters
Walmart’s $6.4B ad business, Sparky’s 35% AOV lift, and a four-point operating leverage spread decide whether this is retail or media.
Chips Can’t Be Made Without Tungsten. China Just Proved It.
APT prices have surged since early 2026. Almonty is ramping Sangdong and just expanded a 21-year offtake tied to current APT pricing.
Trump Threatens a Gulf Mediator. Read the Refiner Trade.
The Oval Office produced a market-moving headline on Monday that most equity desks are still processing. President Trump told Fox…